|
Jul 17
|
Recursion Pharmaceuticals Rises 6% in a Month: How to Play the Stock
|
|
Jul 17
|
Novartis Beats on Q2 Earnings and Sales, CFO Retires, Stock Down
|
|
Jul 16
|
Bayer Extends CEO’s Contract Through 2029
|
|
Jul 16
|
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
|
|
Jul 16
|
BAYRY Skyrockets 62.9% YTD: Should You Buy or Sell the Stock?
|
|
Jul 16
|
for Agriculture, Forestry, and Land Use Carbon Credits Market Analysis Report 2025 | Blockchain Tokenization and Retail Access, & Blended Finance Structures Fueling Opportunities
|
|
Jul 15
|
Connecticut wants to make generic GLP-1s. Will RFK Jr. lend a hand?
|
|
Jul 15
|
Will Key Drugs Maintain Momentum for Novartis in Q2 Earnings?
|
|
Jul 15
|
AstraZeneca Meets All Key Goals in Phase III Hypertension Study
|
|
Jul 15
|
Ultragenyx Pharmaceuticals Gets CRL for UX111 Gene Therapy for MPS IIIA
|
|
Jun 30
|
U.S. Supreme Court Asks for Views of Solicitor General in Durnell Case
|
|
Jun 27
|
Biopesticides Industry Research and Forecast Report 2021-2031 with Competitive Analysis of Corteva, Syngenta, BASF, Bayer, Koppert Biological Systems, and Certis Biologicals
|
|
Jun 25
|
KRYS Up 4% on Initiating Dosing in Rare Eye Disease Phase III Study
|
|
Jun 25
|
Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU
|
|
Jun 25
|
EY US & Bayer Win “Artificial Intelligence for Good” Award in 2025 AI Breakthrough Awards Program
|
|
Jun 24
|
CHMP Backs NVO's Ozempic EU Label Update for Cardiovascular Indication
|
|
Jun 23
|
Exelixis Surges On Positive Results For Next-Gen Colon Cancer Drug
|
|
Jun 13
|
Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year?
|
|
May 24
|
Trump Trade: Trump considers 50% tariff on EU, 25% on iPhones
|
|
May 23
|
Bayer Gets CHMP Nod for Eylea 8 mg in the EU for 2 Major Eye Diseases
|